DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar kalcaps (26.55) Submitted: 10/2/2007 5:24:08 PM : Outperform Start Price: $64.49 DVA Score: +36.80

healthcare play!

Featured Broker Partners


Advertisement